INTERNATIONAL PATENT: ELEDON PHARMACEUTICALS, INC. FILES APPLICATION FOR "USE OF ANTI-CD40 LIGAND ANTIBODIES FOR IMMUNOSUPPRESSION IN ISLET CELL TRANSPLANTATION"

GENEVA, Nov. 19 -- ELEDON PHARMACEUTICALS, INC. (19800 MacArthur BoulevardSuite 250Irvine, California 92612) filed a patent application (PCT/US2025/028223) for "USE OF ANTI-CD40 LIGAND ANTIBODIES FOR IMMUNOSUPPRESSION IN ISLET CELL TRANSPLANTATION" on May 07, 2025. With publication no. WO/2025/235670, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PERRIN, Steven N. (100 Northern Blvd.Newbury, Massachusetts 01951)

Abstract: The disclosure provides uses of anti-CD40 ligand antibodies for immunosuppression in islet cell tr...